Navigating Oncology Clinical Trials: From Drug Development to Delivery

Oncology clinical trials are essential to advancing translational science, providing a pathway from laboratory research to real-world treatments. This article provides an overview of the informed consent process and the drug.

Authors

Institutions

Publication Details

Journal
Clinical journal of oncology nursing
Published
2025-02-01
DOI
https://doi.org/10.1188/25.cjon.91-95
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating Oncology Clinical Trials: From Drug Development to Delivery

Michael Goodman, John Bourgeois, Catherine Braga
Clinical journal of oncology nursing
PARP inhibition in cancer therapy
article

Navigating Oncology Clinical Trials: From Drug Development to Delivery

Michael Goodman, John Bourgeois, Catherine Braga
article en

Abstract

Oncology clinical trials are essential to advancing translational science, providing a pathway from laboratory research to real-world treatments. This article provides an overview of the informed consent process and the drug.

Clinical journal of oncology nursingVol. 29(1)
St. Catherine University (JP), Goodman Research Group (United States) (US), Université d'Artois (FR)
Openalex Percentile: Top 96%
PARP inhibition in cancer therapy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.